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The epidermal growth factor (EGF) transduces its actions via the EGF receptor (EGFR), which can trafﬁc
from the plasma membrane to either the cytoplasm or the nucleus. However, the mechanism by which
EGFR reaches the nucleus is unclear. To investigate these questions, liver cells were analyzed by
immunoblot of cell fractions, confocal immunoﬂuorescence and real time confocal imaging. Cell fraction-
ation studies showed that EGFR was detectable in the nucleus after EGF stimulation with a peak in
nuclear receptor after 10 min. Movement of EGFR to the nucleus was conﬁrmed by confocal immunoﬂu-
orescence and labeled EGF moved with the receptor to the nucleus. Small interference RNA (siRNA) was
used to knockdown clathrin in order to assess the ﬁrst endocytic steps of EGFR nuclear translocation in
liver cells. A mutant dynamin (dynamin K44A) was also used to determine the pathways for this trafﬁc.
Movement of labeled EGF or EGFR to the nucleus depended upon dynamin and clathrin. This identiﬁes
the pathway that mediates the ﬁrst steps for EGFR nuclear translocation in liver cells.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
EGFR is a receptor tyrosine kinase (RTK) that is activated by
binding to its ligands [1,2]. The EGFR ligand complex forms homo
or hetero dimers resulting in EGFR autophosphorylation and acti-
vation [1]. The activated EGFR is rapidly internalized into early
endosomes and subsequently recycled to the plasma membrane
or sorted to late endosomes–lysosomes for degradation [3,4]. Inter-
nalization into endosomal vesicles and degradation in lysosomes is
thought to be the mechanism to terminate receptor activation [5].
Recent evidence has identiﬁed additional intracellular destina-
tions for the internalized receptor as well, including the nucleus
[6,7]. Over the past decade, evidence has accumulated showing
that either full-length or fragmented EGFR family members can
be shuttled from the plasma membrane to the nucleus [8–12]. In-
creased nuclear localization of the EGFR is associated with poor
prognosis of tumors and treatment resistance [13].
The mechanisms proposed for nuclear transport of membrane
proteins include the activity of transmembrane domain-binding
chaperones, endosome-mediated nuclear translocation, and retro-ochemistry and Immunology,
os 6627, Belo Horizonte, MG
s).
lsevier OA license.translocation by endoplasmic reticulum (ER)-associated trafﬁcking
machinery [7,14–16]. Although certain intracellular trafﬁcking
destinations for activated EGFRs, such as the lysosome or recycling
to the cell surface, are relativelywell understood [17], little is known
regarding the mechanism by which this or other cell surface recep-
tors reach the nucleus.
Regardless of some authors assume that EGFR is internalized by
clathrin dependent pathway, there is no available data directly
showing the roles of this pathway on EGFR nuclear translocation.
Hence, the aim of this work was to elucidate the ﬁrst endocytic
step that mediates the EGFR nuclear translocation in liver cells.2. Materials and methods
2.1. Cells and cell culture
SKHep-1 liver cell line was obtained from ATCC (Manassas, VA).
Cells were cultured at 37 C in 5% CO2 in Dulbecco’s modiﬁed
Eagle’s medium (Invitrogen, CA) containing 10% fetal bovine ser-
um, 1 mM sodium pyruvate, 50 units/ml penicillin, and 50 g/ml
streptomycin (Invitrogen, CA). Hepatocytes were isolated from
the livers of male Sprague–Dawley rats (190–200 g; Charles River
Laboratories, Wilmington, MA) by collagenase perfusion as
described previously [18,19]. Primary hepatocytes were cultured
at 37 C in 5% CO2/95% O2 in Williams’ medium E containing 10%
fetal bovine serum, 50 units/mL penicillin, and 50 g/mL streptomy-
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mL) (BD Biosciences, CA). Hepatocytes were used 4–6 h after isola-
tion. Viability of the hepatocytes was greater than 85% and was
measured by trypan blue exclusion.
2.2. Immunoblotting
SKHep-1 cell immunoblots were performed as described previ-
ously [11,19–21]. Brieﬂy, cells were washed twice with ice-cold
phosphate-buffered saline, harvested by scraping, and lysed in a ly-
sis buffer (20 mM HEPES, pH 7.0, 10 mM KCL, 2 mM MgCl2, 0.5%
Nonidet P-40). After incubation on ice for 10 min, the cells were
homogenized by vortex. The homogenate was centrifuged at
1500g for 5 min to sediment the nuclei. The supernatant was then
centrifuged at a maximum speed of 16,100g for 20 min, and the
resulting supernatant formed the non nuclear fraction. The nuclear
pellet was washed three times with lysis buffer to remove any con-
tamination from cytoplasmic membranes, and the purity of the nu-
clei was conﬁrmed by light microscopy. To extract nuclear
proteins, the isolated nuclei were resuspended in NETN buffer
(150 mM NaCl, 1 mM EDTA, 20 mM Tris–HCl, pH 8.0, 0.5% Nonidet
P-40), and the mixture was sonicated brieﬂy to aid nuclear lysis.
Nuclear lysates were collected after centrifugation at 16,100g for
20 min at 4 C. Protease and phosphatase inhibitors (Sigma, MO)
were added to all buffers. The purity of nuclear and non-nuclear
fractions was conﬁrmed using Lamin B1 (Abcam, MA) as a nuclear
marker and a-tubulin (Sigma, MO) as a non nuclear marker
[19–21]. The membrane was blocked with 5% skim milk in TBST
(TBS plus 0.1% Tween 20) for 60 min and then incubated with pri-
mary antibody. Commercially available antibodies for EGFR (Santa
Cruz, CA), anti-phospho-EGFR (Tyr1173) (Millipore, MA) and anti-
clathrin heavy chain 2 (BD, CA) were used. Incubations were car-
ried out overnight. After three washes with TBST, the membranes
were incubated with peroxidase-conjugated secondary antibody
(1:5000) (Sigma, MO) for 1 h at room temperature. Blots were visu-
alized by enhanced chemiluminescence and quantitatively ana-
lyzed using ImageJ software.
2.3. Confocal ﬂuorescence microscopy
Both confocal immunoﬂuorescence and time lapse imagingwere
performed. Confocal immunoﬂuorescence was performed as de-Fig. 1. EGF receptor rapidly translocates to the nucleus in liver cells. (A) Immunoblots of
of SKHep-1 cells stimulated with EGF (100 ng/mL) are shown. a-tubulin and Lamin B1 w
Total as well as phosphorylated EGFR are detected in the nucleus within 5 min of stimul
hepatocytes stimulated with EGF (100 ng/mL). Blots are representative of what was obsscribed previously [19–21]. Cells were double-labeled with a poly-
clonal antibody against EGFR (Santa Cruz, CA) and a monoclonal
antibody against the nuclearmembranemarker Lamin-B1, and then
incubated with secondary antibodies conjugated to Alexa 488 and
555 (Invitrogen, CA), respectively. Intracellular trafﬁcking of EGF
was examined by time lapse confocal imaging of EGF labeled with
Alexa488or 555 (Invitrogen, CA). All confocal imageswere collected
with a Zeiss LSM510 confocalmicroscope using a 63, 1.4NAobjec-
tive lens with excitation at 488 nm and observation at 505–550 nm
to detect Alexa 488, and excitation at 543 nm and observation at
560–610 nm to detect Alexa 555.
2.4. Cell transfection
SKHep-1 cells were transfected using Lipofectamine 2000
according to the manufacturer’s instructions (Invitrogen, CA) with
50 nM siRNA for Clathrin Heavy Chain (CHC2) (siRNA ID
AM16106) (Ambion, TX). Constructs encoding GFP-dynamin and
GFP-dynamin K44Awere kindly provided by Pietro De Camilli (Yale
University). Transfected cells were incubated at 37 C in an atmo-
sphere of 5% CO2, 95% O2 for 48 h prior to use.
2.5. Statistical Analysis
One-way ANOVA followed by Bonferroni’s post hoc compari-
sons tests were performed in all statistical analyses. Data are rep-
resented as mean ± standard error.
3. Results
3.1. EGF/EGFR complex translocates to the nucleus
Studieswere performed in the SKHep-1 human liver cell line and
primary hepatocytes because of the well known effects of EGF in li-
ver [22]. Immunoblot analysis of extracts from SKHep-1 cells was
used to observe total and phosphorylated EGFR translocation to
the nucleus. Cell fractionation showed that EGFR appears in the nu-
cleus and reaches a peak there within 10 min (Fig. 1A). Phosphory-
lated receptor can be detected in the nucleus within 5 min of
stimulation, which is the earliest time point examined (Fig. 1A).
The EGFR also translocates to the nucleus in hepatocytes (Fig. 1B).
SKHep-1 cells were used for all next experiments to circumventtotal and phosphorylated EGF receptor (pEGFR) in non nuclear and nuclear fractions
ere used as purity controls for the non nuclear and nuclear fractions, respectively.
ation. (B) Immunoblots of total EGF receptor in non nuclear and nuclear fractions of
erved in three separate experiments.
Fig. 2. EGF from the plasma membrane travels with EGFR to the nucleus. (A) Time lapse confocal images of SKHep-1 cells stimulated with EGF-Alexa 488 (100 ng/mL). Cells
were transfected with mRFP tagged with a nuclear localization signal (mRFP-NLS) (Red) and after 48 h the cells were stimulated with EGF-Alexa 488 (Green). EGF-Alexa 488
labeling is initially along the plasma membrane and then moves into the cytoplasm and then the nucleus (arrows). Images are representative of what was observed in three
separate experiments. (B) Confocal immunoﬂuorescence images 10 min after stimulation with EGF-Alexa 488. EGF-Alexa 488 is in green, Lamin B1 is in red and the nucleus is
stained with TO-PRO-3 (blue). Serial optical sections were collected for three-dimensional reconstruction; x-z sections are shown at the top, and y-z sections are shown at the
right of each image. Note that EGF-Alexa 488 is in the interior of the nuclear region (arrows). The images conﬁrm that the EGF moves to the nucleus. Images are representative
of what was observed in 11 separate cells. (C) Confocal immunoﬂuorescence images 10 min after stimulation with EGF-Alexa 488 (100 ng/mL). The left top panel shows
subcellular distribution of EGF-Alexa 488 (Green), the top right EGFR (Red), the bottom left nuclear staining with Hoechst (Blue), and the bottom right panel shows the
merged image. The merged image demonstrates that EGFR co-localizes with EGF within both the cytoplasm and nucleus (arrows). Images are representative of what was
observed in 20 separate cells. Scale Bar = 10 lm.
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mary hepatocytes.Confocal microscopy was performed to conﬁrm the nuclear
localization of the EGF/EGFR complex in SKHep-1 cells. First, time
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EGF-Alexa 488. SKHep-1 cells were transfected with monomeric
Red Fluorescent Protein (mRFP) tagged with a nuclear localization
signal (mRFP-NLS) to identify the nuclear region, and then stimu-
lated with EGF-Alexa 488 (100 ng/mL). EGF was detected within
the nucleus 10–12 min after stimulation, as observed by the co-
localization of EGF with mRFP-NLS (Fig. 2A). Three-dimensional
reconstruction of serial confocal immunoﬂuorescence images con-
ﬁrmed that the EGF-Alexa 488 was localized to the nuclear interior
(Fig. 2B). Confocal immunoﬂuorescence was performed to visualize
the subcellular distribution of the EGF/EGFR complex (Fig. 2C). The
images show that ligand/receptor complex can be found within
both the cytoplasm and nucleus (Fig. 2C). Together, these ﬁndings
demonstrate that both total and activated EGFR rapidly translocate
to the nucleus upon stimulation of cells with EGF, and suggest that
EGF can move with its receptor to the nucleus.
3.2. Internalization of EGF is dynamin-dependent
To investigate the dependence of dynamin on EGFR nuclear
translocation we over-expressed dynamin or a dominant negative
form of dynamin (K44A), each conjugated to a Green Fluorescent
Protein (GFP). The dominant negative form of dynamin lacks the
GTPase activity needed to activate the function of this protein
[23]. SKHep-1 cells were transfected with either construct and
were stimulated 48 h later with EGF-Alexa 555 (100 ng/ml) for
10 min (Fig. 3). Cells that over-expressed the wild type form of
dynamin showed EGF distributed throughout the cell (Top panel,
Fig. 3). In contrast, EGF accumulated along the region of the plasma
membrane in cells over-expressing the dominant negative form of
dynamin (K44A-GFP) (Bottom panel, Fig. 3) and consequently
blocks the nuclear trafﬁcking of EGF. These results suggest that
internalization of EGF is dynamin-dependent, as has been sug-
gested by others [24,25].3.3. Translocation of EGFR to the nucleus depends upon clathrin
A previously Ambion validated clathrin (CHC2) siRNA reduced
clathrin expression in SKHep-1 cells by 85.4 ± 6.5% (p < 0.01)Fig. 3. Internalization of EGFR is dynamin-dependent. Confocal immunoﬂuorescence im
were transfected with a WT Dynamin (top panels) or a dominant negative form of Dyn
(green). Nuclear staining with Hoechst is shown in blue. Cells were stimulated with
internalized in cells transfected with WT dynamin but remains concentrated along the pl
representative of what was observed in 15 separate cells under each experimental cond(Fig. 4A). Scrambled siRNA had no effect on clathrin expression
(p > 0.05) (Fig. 4A). SKHep-1 cells were transfected using these siR-
NAs and then stimulated for 10 min with EGF 48 h later. Immuno-
blots of nuclear and non-nuclear cell fractions demonstrated that
treatment of cells with clathrin siRNA block the translocation of
EGFR to the nucleus (p > 0.05) (Fig. 4B). Confocal immunoﬂuores-
cence was performed to directly visualize the subcellular localiza-
tion of EGFR in these cells (Fig. 4C). After 10 min of EGF stimulation
EGFR was localized in the nucleus in Scramble siRNA-treated cells,
but was excluded from the nucleus in the CHC2 siRNA-treated cells
(Fig. 4C). Together, these results show that clathrin is necessary for
EGFR nuclear translocation.4. Discussion
EGF acts through the EGFR, and evidence from other RTKs sug-
gests that translocation to the nucleus may be a common feature
for this class of receptors. A number of RTKs have been found in
the nucleus, including the hepatocyte growth factor receptor
(c-met), ﬁbroblast growth factor receptor (FGFR), insulin receptor,
vascular endothelial growth factor receptor (VEGFR), and the four
members of the EGFR family [8,19,21,26–30]. Total and phosphor-
ylated EGF receptor can be found in the nucleus within 5 min of
stimulation with EGF, and reaches peak levels within 10 min. Here
we demonstrated that EGF and its receptor translocates to the nu-
cleus in liver cells. EGF nuclear transport was monitored by real
time imaging suggesting that the ligand travels with its receptor
to the nucleus. It had been demonstrated that clathrin-mediated
endocytosis is required for EGFR internalization and that it plays
roles in attenuation of some EGFR responses and also controlling
speciﬁc signaling pathways [31,32]. However, whether EGFRs des-
tined for the nucleus also use this endocytic pathway has not been
examined directly in liver cells.
The current work suggests that this process is dynamin-depen-
dent, which is consistent with the previous observation that tran-
sient expression of the K44A dynamin dominant negative mutant
in CHO cells dramatically reduces nuclear EGFR expression levels
[23]. The current work provides evidence that dynamin and clath-
rin are necessary ﬁrst steps for translocation of EGFR to the nu-ages are shown 10 min after stimulation with EGF-Alexa 555 (red). SKHep-1 cells
amin (K44A) (bottom panels), both tagged with a green ﬂuorescent protein (GFP)
EGF-alexa 555 (100 ng/mL) 48 h after transfection. Note that EGF-Alexa 555 is
asma membrane region in cells transfected with Dynamin K44A (arrow). Images are
ition. Scale Bar = 10 lm.
Fig. 4. Knockdown of Clathrin blocks translocation of EGFR to the nucleus. (A) SKHep-1 cells were transfected with clathrin heavy chain 2 (CHC2) siRNA (50 nM).
Immunoblots was performed to quantify the knockdown of CHC2 (left panel) and densitometric analysis conﬁrms that it reduced protein expression by 85.4 ± 6.5% (n = 3,
⁄p < 0.05) (right panel). Scramble siRNA was used and it didn’t reduce CHC2 expression level. (B) SKHep-1 cells were transfected with CHC2 or Scramble siRNAs and
stimulated 48 h later with EGF (100 ng/mL) for 10 min. The amount of EGFR in the treated group with CHC2 siRNA and EGF didn’t alter in the non nuclear and in the nuclear
fractions compared with control cells (p > 0.05). a-tubulin and Lamin B1 were used as purity controls for the non nuclear and nuclear fraction, respectively. Blot is
representative of what was observed in nine separate experiments. (C) Confocal immunoﬂuorescence images 10 min after stimulation with EGF (100 ng/mL). SKHep-1 cells
were trasfected with Scramble or CHC2 siRNAs 48 h before the stimulation with EGF. EGFR and Lamin B1 were labeled with Alexa-488 (green) and Alexa-555 (red),
respectively. Nuclear staining with Hoechst is shown in blue. Note that in CHC2 siRNA-treated cells the EGFR are concentrated outside the nucleus. Images are representative
of what was observed in 20 cells under each experimental condition. ⁄⁄p < 0.001. Scale Bar = 10 lm.
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chalasin D inhibited the nuclear accumulation of EGFR [33]. In con-
trast, other report showed that ErbB3 nuclear translocation is
clathrin-independent in prostate cancer cell lines [34]. This contra-
dictory result may be due the different receptors or cells used for
these experiments.
How does EGFR move to the nucleus after it has undergone
endocytosis? Accumulating evidence suggests the existence of a
novel pathway by which internalized cell surface RTKs within early
endosomes are transported to the nucleus rather than back to the
cell surface or to lysosomes [6,7]. A retrograde route from Golgi to
ER is thought to be involved in EGFR trafﬁcking to the nucleus. Nu-
clear transport of EGFR also is regulated by COPI-mediated vesicu-
lar trafﬁcking from the Golgi to the ER [35]. In addition, the Sec61
translocon associates with EGFR, and is retrotranslocated from the
ER to the cytoplasm [16,36]. HSP70 is essential in the retrotranslo-
cation process and likely functions by interacting with the receptor
transmembrane domain and thereby maintaining the receptor in a
soluble state following extraction from the ER membrane [36].
EGFR as a cytoplasmic protein likely interacts with importin-b
and then enters the nucleus through the nuclear pore complex
[8,23]. Further work will be needed to understand the relative roles
of nuclear and non-nuclear EGFR in cell signaling, and to identify
how the proportions of EGFRs that are destined for the various pos-
sible intracellular locations are regulated.
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